drugset
drugset / Trial / NCT04711915

Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans

NCT04711915 ↗

Phase 1 Active not recruiting 30 enrolled Yale University
Non-randomizedCrossoverOpen-labelOther

Summary

The goal of this fixed order, open-label, dose-escalation study is to investigate the safety and efficacy of specific doses of dimethyltryptamine (DMT) in humans.

Timeline

Start
2021-03-17
Primary completion
2026-07-01
Completion
2026-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dimethyltryptamine Unknown 0.1 mg/kg Intravenous
Comparator Dimethyltryptamine Unknown 0.3 mg/kg Intravenous

Indications

major depressive disorder